Preoperative Nutritional Status Is an Important Predictor of Survival in Patients Undergoing Surgery for Renal Cell CarcinomaTodd M. Morgan, Peter E. Clark, Dominic H. Tang et al.|European Urology|2011Cited by 147
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605Peter C. Black, Seth P. Lerner, Catherine M. Tangen et al.|European Urology|2023Cited by 96
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E. Eggener, William T. Lowrance, Ketan K. Badani et al.|The Journal of Urology|2015Cited by 82
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinomaSamuel D. Kaffenberger, Peter E. Clark, Todd M. Morgan et al.|British Journal of Urology|2012Cited by 55
Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).Peter C. Black, Ian M. Thompson, Kelly Stratton et al.|Journal of Clinical Oncology|2020Cited by 55